Editorial: "lean" NAFLD: Metabolic Obesity with Normal BMI... Is It in the Genes¿

American Journal of Gastroenterology

Volumn 112, Issue 1, 2017, Pages 111-113

  Argo, Curtis K ^a   Henry, Zachary H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; BRANCHED CHAIN AMINO ACID; CERAMIDE; HEMOGLOBIN A1C; INSULIN; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ABDOMINAL OBESITY; ALLELE; ANTHROPOMETRIC PARAMETERS; AUSTRIA; BODY COMPOSITION; BODY MASS; CARBOHYDRATE INTAKE; CARDIORESPIRATORY FITNESS; CAUCASIAN; COLON CANCER; DIET; ECHOGRAPHY; EXERCISE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLOMICS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WAIST CIRCUMFERENCE; FATTY LIVER; LIVER;

BODY MASS INDEX; FATTY LIVER; HUMANS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 85008391954     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.527     Document Type: Review

References (14)

1. Younossi ZM, Koenig AB, Abdelatif D et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84.
2. Feldman A, Eder SK, Felder TK et al. Clinical and metabolic characterization of lean Caucasian subjects with nonalcoholic fatty liver. Am J Gastroenterol 2016; 112: 102-10 (this issue).
3. Feng RN, Du SS, Wang C et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014; 20: 17932-40.
4. Kim HJ, Kim HJ, Lee KE et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 2169-75.
5. Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012; 27: 1555-60.
6. Alam S, Gupta UD, Alam M et al. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol 2014; 33: 452-7.
7. Younossi ZM, Stepanova M, Negro F et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 2012; 91: 319-27.
8. Dela Cruz AC, Bugianesi E, George J et al. Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease. Gastroenterology 2014; 146 (5 Suppl1): A379.
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
10. Lichtman SW, Pisarska K, Berman ER et al. Discrepancy between selfreported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992; 327: 1893-8.
11. Cheng S, Wiklund P, Autio R et al. Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease. PLoS One 2015; 10: e0138889.
12. Sunny NE, Kalavalapalli S, Bril F et al. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab 2015; 309: E311-9.
13. Rotman Y, Koh C, Zmuda JM et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
14. Sookoian S, Pirola CJ. Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis. Hepatology 2016; 64: 1417-20.